The abscopal effect of radiation therapy.


Journal

Future oncology (London, England)
ISSN: 1744-8301
Titre abrégé: Future Oncol
Pays: England
ID NLM: 101256629

Informations de publication

Date de publication:
May 2021
Historique:
pubmed: 18 3 2021
medline: 6 11 2021
entrez: 17 3 2021
Statut: ppublish

Résumé

Radiation therapy (RT) in some cases results in a systemic anticancer response known as the abscopal effect. Multiple hypotheses support the role of immune activation initiated by RT-induced DNA damage. Optimal radiation dose is necessary to promote the cGAS-STING pathway in response to radiation and initiate an IFN-1 signaling cascade that promotes the maturation and migration of dendritic cells to facilitate antigen presentation and stimulation of cytotoxic T cells. T cells then exert a targeted response throughout the body at areas not subjected to RT. These effects are further augmented through the use of immunotherapeutic drugs resulting in increased T-cell activity. Tumor-infiltrating lymphocyte presence and TREX1, KPNA2 and p53 signal expression are being explored as prognostic biomarkers.

Identifiants

pubmed: 33726502
doi: 10.2217/fon-2020-0994
doi:

Substances chimiques

Biomarkers, Tumor 0
Immune Checkpoint Inhibitors 0
KPNA2 protein, human 0
Phosphoproteins 0
TP53 protein, human 0
Tumor Suppressor Protein p53 0
alpha Karyopherins 0
Exodeoxyribonucleases EC 3.1.-
three prime repair exonuclease 1 EC 3.1.16.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1683-1694

Auteurs

Daniel J Craig (DJ)

Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH 43614, USA.

Nisha S Nanavaty (NS)

Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH 43614, USA.

Monika Devanaboyina (M)

Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH 43614, USA.

Laura Stanbery (L)

Department of Medical Affairs, Gradalis, Inc, Carrollton, TX 75006, USA.

Danae Hamouda (D)

Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH 43614, USA.

Gerald Edelman (G)

Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH 43614, USA.
Promedica Health System, Toledo, OH 43606, USA.

Lance Dworkin (L)

Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH 43614, USA.

John J Nemunaitis (JJ)

Department of Medical Affairs, Gradalis, Inc, Carrollton, TX 75006, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH